Satis Pharmaceutical starts accepting new customers from September 1st

 Satis Pharmaceutical Co., Ltd., which is engaged in OEM business specializing in mail-order and D2C brands, will resume accepting new brand development, which had been suspended for two years, from September 1.

For the past two years, we have strengthened our manufacturing base by focusing on internal reforms in order to concentrate on the business contributions of existing customers.

Comments

Popular posts from this blog

L'Oréal forms research and technology alliance with Israeli climate tech company

"THE SONOKO White Mask" for moisturizing and transparent skin of adults

L'Oreal Research & Innovation, Morishita Jintan Co., Ltd. and L'Oreal's first successful development of cutting-edge "active delivery capsules" made of useful ingredients for plant-derived cosmetics